|
Session 126-Poster Abstracts
Hepatitis C: Epidemiology and Outcomes
Friday, 2-4 pm; Poster Hall |
643
 |
Hepatitis C Epidemic among HIV+ Men Who Have Sex with Men Started before 2000
Jannie van der Helm*1, R Geskus2, J del Amo3, G Chêne4, J Gill5, O Hamouda6, M Sannes7, K Porter8, M Prins1,2, and CASCADE Collaboration
1Publ Hlth Svc, Amsterdam, The Netherlands; 2Academic Med Ctr, Univ of Amsterdam, The Netherlands; 3Inst de Salud Carlos III, Madrid, Spain; 4Univ Victor Segalen Bordeaux, France; 5Southern Alberta HIV Clin, Sheldon M Chumir Hlth Ctr, Calgary, Canada; 6Robert Koch Inst, Berlin, Germany; 7Oslo Univ Hosp, Ullevål, Norway; and 8Med Res Council Clin Trials Unit, London, UK |
644
|
Declining HCV Incidence over 20 Years among HIV Positive and Negative IDU in Baltimore, MD (1988 to 2008)
S Mehta1, J Astemborski1, G Kirk1,2, K Nelson1, and David Thomas*1,2
1Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US and 2Johns Hopkins Univ Sch of Med, Baltimore, MD, US |
645
|
Incidence, Genotype Distribution, and Prognosis of Sexually Transmitted Acute Hepatitis C in a Cohort of HIV-infected Patients
Hans-Jürgen Stellbrink*1, K Schewe1, M Vogel2, C Hoffmann3, and C Noah3
1ICH, Hamburg, Germany; 2Universitätsklinik Bonn, Germany; and 3IPM Biotech GmbH, Hamburg, Germany |
| 646 |
Molecular Epidemiology of HCV Genotypes among Injection Drug Users in Taiwan: Identification of a New Subtype 6v and Unique Recombinant Form_2b6v
Y-M Lee1,2,3,4, H-J Lin3,5, Y-J Chen3,4, C-M Lee1, S-F Wang5, K-Y Chang1, T-L Chen1,2, Hsin-Fu Liu*5, and Y-M Chen1,2,4
1AIDS Prevention and Res Ctr, Natl Yang-Ming Univ, Taipei, Taiwan; 2Inst of Publ Hlth, Natl Yang-Ming Univ Sch of Med, Taipei, Taiwan; 3St Paul’s Hosp, Tao-Yuan, Taiwan; 4Natl Yang-Ming Univ Sch of Life Sci, Taipei, Taiwan; and 5Natl Yang-Ming Univ Sch of Biomed Sci and Engineering, Taipei, Taiwan |
647
|
Factors Associated with Hepatitis C Viral Load in a Nation-wide French Cohort of HIV/HCV Co-infected Patients: ANRS C013 HEPAVIH
Pascale Trimoulet*1, L Merchadou2, M-A Loko2, M Winnock2, M-A Valantin3, I Poizot-Martin4, H Fleury1, D Salmon5, F Dabis2, D Neau1, and ANRS CO13 HEPAVIH Study Group
1Univ Hosp Bordeaux, France; 2INSERM U897, Bordeaux, France; 3INSERM U943, Paris, France; 4Univ Hosp Marseille, France; and 5Univ Hosp Paris, France |
648
|
Impact of HTLV-1 Simultaneous Infection on the Curse of HIV/HCV Co-infected Patients
Fabianna Bahia*, V Novais, S Stolze, E Netto, and C Brites
Federal Univ of Bahia, Brazil |
649
|
Factors Associated with Liver Disease Severity in a Cohort of Patients with HIV
Irine Vodkin*1, B Aouizerat2, S Deeks2, J Martin2, and M Peters2
1Stanford Univ, CA, US and 2Univ of California, San Francisco, US |
650
|
All-cause Mortality in HIV-infected Patients in Spain Compared to the General Population according to HCV Status
Santiago Perez Cachafeiro*1, C Lewden2, V Hernando1, J A Iribarren3, J A Oteo4, J L Gomez Sirvent5, J Hernandez Quero6, M Masia7, S Moreno8, J Del Amo1, and CoRIS/CoRIS-MD
1Hosp Carlos III, Madrid, Spain; 2INSERM U897, Univ Bordeaux 2, France; 3Hosp Donostia, San Sebastian, Spain; 4Hosp San Pedro, La Rioja, Spain; 5Hosp Univ Canarias, Tenerife, Spain; 6Hosp Univ San Cecilio, Granada, Spain; 7Hosp Univ Elche, Spain; and 8Hosp Univ Ramon y Cajal, Madrid, Spain |
|
